Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04681352 · ClinicalTrials.gov registry record · NA
A Study of Octave System for Improving Lines and Wrinkles of the Décolleté
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT04681352 is a NA study that has completed, run by Merz North America. The registered enrollment target is 99 participants.
The verdict
NCT04681352, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.
Interventions
- DEVICE Octave-Ultherapy treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2020-12-29 |
| Est. Completion | 2022-02-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04681352
The ClinicalTrials.gov registry entry for NCT04681352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Octave-Ultherapy treatment is the first listed.
NCT04681352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04681352 about?
NCT04681352 is a clinical study titled "A Study of Octave System for Improving Lines and Wrinkles of the Décolleté". To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.
What is the current status of trial NCT04681352?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2020-12-29. Estimated completion is 2022-02-21.
What interventions are being tested in trial NCT04681352?
The interventions under investigation include: Octave-Ultherapy treatment (DEVICE).
Who is sponsoring clinical trial NCT04681352?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.